Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/5/25 18:00 | 9/4/25 | JNJ | Health | Drug | Pharmaceutical Preparations | Taubert Jennifer L | NJ | O | EVP,WWC. | 1 | S.d | -10,041 | 177.81 | 0 | -56 | 178 | D | |||||||||||||||
8/25/25 19:12 | 8/22/25 | JNJ | Health | Drug | Pharmaceutical Preparations | Duato Joaquin | NJ | DO | CEO,CB | 1 | S.d | -22,549 | 179.21 | 0 | -126 | 408 | D | |||||||||||||||
8/18/25 18:19 | 8/15/25 | JNJ | Health | Drug | Pharmaceutical Preparations | Wolk Joseph J | NJ | O | EVP,CFO | 2 | S.d | -4,978 | 166.87 | 0 | -30 | 85 | D | |||||||||||||||
7/18/25 16:12 | 7/17/25 | JNJ | Health | Drug | Pharmaceutical Preparations | Reed John C | NJ | O | EVP,Inno | 1 | S | -3,130 | 163.55 | 0 | -19 | 11 | D | |||||||||||||||
2/26/25 18:42 | 8/30/24 | JNJ | Health | Drug | Pharmaceutical Preparations | Decker Robert J | NJ | O | VP Corpo | 2 | S.d | -2,091 | 165.51 | 0 | -13 | 22 | D | |||||||||||||||
2/18/25 21:33 | 2/18/25 | JNJ | Health | Drug | Pharmaceutical Preparations | Schmid Timothy | NJ | O | EVP,WW C | 1 | S.d | -63 | 156.15 | 0 | 0 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |